Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
36 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • News

II-VI Q1 EPS $0.87 Beats $0.83 Estimate, Sales $795.00M Miss $808.60M Estimate

By 8
November 9, 7:58 AM
II-VI (NASDAQ:IIVI) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.83 by 4.82 percent. This is a 3.57 percent increase over earnings of $0.84 per share from the same period

IIVI

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Needham Downgrades Conduent to Hold

By 8
November 9, 6:17 AM
Needham analyst Mayank Tandon downgrades Conduent (NASDAQ:CNDT) from Buy to Hold.

CNDT

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Needham Initiates Coverage On Paragon 28 with Buy Rating, Announces Price Target of $31

By 8
November 9, 6:15 AM
Needham analyst Mike Matson initiates coverage on Paragon 28 (NYSE:FNA) with a Buy rating and announces Price Target of $31.

FNA

Read More
1 minute read
  • FDA
  • Movers
  • News
  • Trading Ideas

Biogen Shares Move Higher; Traders Circulate BlueCrossBlueShield Posting SHowing Co’s Aduhelm Considered ‘Medically Necessary’ For Treatment Of Alzheimers

By 8
November 2, 2:35 PM
https://www.bcbst.com/DraftMPs/Aducanumab-avwa_pol.pdf

BIIB

Read More
1 minute read
  • FDA
  • Movers
  • News
  • Trading Ideas

Biogen Shares Move Higher; Traders Circulate BlueCrossBlueShield Posting SHowing Co’s Aduhelm Considered ‘Medically Necessary’ For Treatment Of Alzheimers

By 8
November 2, 2:35 PM
https://www.bcbst.com/DraftMPs/Aducanumab-avwa_pol.pdf

BIIB

Read More
1 minute read
  • Management
  • Movers
  • News
  • Rumors
  • Trading Ideas

Pinterest Shares Spike On Volume Following Report From Variety ‘YouTube Head of Content Partnerships Malik Ducard Exits to Join Pinterest’

By 8
October 25, 3:05 PM
https://variety.com/2021/digital/news/pinterest-malik-ducard-youtube-1235096079/

GOOG

Read More
2 minute read
  • News

Wave Life Sciences Reports Amendment To Central Nervous System Collab With Takeda: Allows For Co. To Advance, Partner On Its Central Nervous System Programs

By 8
October 18, 5:01 PM
Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using ADAR editing Takeda option to co-develop and co-commercialize late-stage CNS programs, including clinical programs

WVE

Read More
1 minute read
  • General
  • News
  • Politics
  • Rumors

‘Democrats to scale back Treasury’s IRS bank reporting plan amid GOP uproar’ -Washington Post

By 8
October 18, 4:24 PM
https://www.washingtonpost.com/us-policy/2021/10/18/democrats-irs-bank-reporting/

SPY

Read More
3 minute read
  • Cannabis
  • FDA
  • Markets
  • News

MyMD Pharmaceuticals Announces Data It Says Demonstrates 8,000 Times Higher Potency Of Novel Synthetic Supera-CBD Over Plant-Derived CBD; Shares Move Higher

By 8
September 22, 11:01 AM
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) ("MyMD" or "the Company"), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating

MYMD

Read More
1 minute read
  • Commodities
  • General
  • Markets
  • Politics

U.S. EPA Considering Cuts To Biofuel Blending Obligations For 2020, 2021, 2022 Years

By 8
September 22, 10:52 AM
-Reuters Citing Document

USO

Posts navigation

Previous 1 2 3 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service